Product details
The Tesamorelin + Ipamorelin pairing combines a GHRH-receptor agonist (Tesamorelin) with a GHSR / ghrelin-receptor agonist (Ipamorelin) — the same dual-pathway architecture as the canonical CJC-1295 + Ipamorelin pairing, with Tesamorelin substituted on the GHRH arm. The two receptors converge on somatotroph signalling, which is the reason the pairing is studied together in somatotropic-axis research. The material is referenced here as a characterized pairing of two standards, not for any GH-secretion outcome.
Consistent with Peptuno's methodology for multi-component systems, the two components are characterized on their own analytical packets rather than presented as a blend whose per-component data is obscured: Tesamorelin and Ipamorelin are each supplied as separately characterized lots — RP-HPLC purity (gradient method, UV 214 nm), ESI-MS identity, sequence confirmation by LC-MS/MS on request, counter-ion content, and water content by Karl Fischer — so each can be confirmed against its own standard before a lab prepares the combination in-protocol. The components carry individual CAS numbers rather than a single registered identifier for the pairing; confirm each component's API by COA / label before use. This is reference-grade research material, distinct from compounding-scale API supply.
Regulatory note: Components carry individual CAS numbers — confirm each component's API identity by batch COA / label before use. Peptuno supplies this pairing strictly for Research Use Only; buyers are responsible for verifying ingredient eligibility in their destination market.
FAQ
- How does the Tesamorelin + Ipamorelin pairing relate to CJC-1295 + Ipamorelin?
- Both pair a GHRH-receptor agonist with the GHSR agonist Ipamorelin to probe the two converging arms of somatotroph signalling; the difference is the GHRH-arm molecule. Tesamorelin and CJC-1295 (no-DAC) differ in their pharmacokinetic profiles, so the two pairings are studied as related but non-identical dual-pathway reference systems. Peptuno supplies each component as an independently characterized lot in either pairing.
- Does Peptuno ship this as a pre-mixed blend?
- No. Tesamorelin and Ipamorelin are supplied as separate characterized lots, each with its own analytical packet, so a lab can confirm the identity and purity of each before preparing the combination in-protocol at its chosen ratio. A pre-mixed vial would obscure the per-component analytical data a citable methods section needs.
- Why does the pairing not carry a single CAS?
- It is a combination of two distinct molecules, each with its own CAS Registry Number, rather than a single chemical entity. Identity is established at the component level on each lot COA; buyers should confirm each component's API by COA or label rather than relying on the pairing name.
Certificate of Analysis (COA)
The per-lot COA for this product will appear here.
Related products
Tesamorelin
GHRH analog · approved for HIV-associated lipodystrophy
Ipamorelin
Ghrelin / GHSR pathway GH-release peptide
CJC-1295 + Ipamorelin
GH-axis blend (CJC-1295 no DAC + Ipamorelin)